Novo Nordisk A/S (NVO)
42.79
+0.60
(+1.42%)
USD |
NYSE |
Jun 10, 16:00
42.71
-0.08
(-0.19%)
After-Hours: 20:00
Novo Nordisk EPS Diluted (TTM) : 4.261 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.261 |
| December 31, 2025 | 3.473 |
| September 30, 2025 | 3.437 |
| June 30, 2025 | 3.634 |
| March 31, 2025 | 3.376 |
| December 31, 2024 | 3.283 |
| September 30, 2024 | 3.084 |
| June 30, 2024 | 2.914 |
| March 31, 2024 | 2.896 |
| December 31, 2023 | 2.702 |
| September 30, 2023 | 2.406 |
| June 30, 2023 | 2.105 |
| March 31, 2023 | 1.893 |
| December 31, 2022 | 1.730 |
| September 30, 2022 | 1.683 |
| June 30, 2022 | 1.671 |
| March 31, 2022 | 1.679 |
| December 31, 2021 | 1.651 |
| September 30, 2021 | 1.607 |
| June 30, 2021 | 1.535 |
| March 31, 2021 | 1.443 |
| December 31, 2020 | 1.374 |
| September 30, 2020 | 1.326 |
| June 30, 2020 | 1.300 |
| March 31, 2020 | 1.269 |
| Date | Value |
|---|---|
| December 31, 2019 | 1.228 |
| September 30, 2019 | 1.225 |
| June 30, 2019 | 1.196 |
| March 31, 2019 | 1.233 |
| December 31, 2018 | 1.265 |
| September 30, 2018 | 1.260 |
| June 30, 2018 | 1.282 |
| March 31, 2018 | 1.238 |
| December 31, 2017 | 1.166 |
| September 30, 2017 | 1.151 |
| June 30, 2017 | 1.129 |
| March 31, 2017 | 1.129 |
| December 31, 2016 | 1.112 |
| September 30, 2016 | 1.099 |
| June 30, 2016 | 1.051 |
| March 31, 2016 | 0.9932 |
| December 31, 2015 | 1.005 |
| September 30, 2015 | 0.978 |
| June 30, 2015 | 0.9557 |
| March 31, 2015 | 0.9598 |
| December 31, 2014 | 0.8969 |
| September 30, 2014 | 0.8942 |
| June 30, 2014 | 0.8861 |
| March 31, 2014 | 0.8606 |
| December 31, 2013 | 0.8319 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AstraZeneca PLC | 3.330 |
| GSK Plc | 3.824 |
| Johnson & Johnson | 8.649 |
| Eli Lilly & Co. | 27.78 |
| Merck & Co., Inc. | 3.553 |